Related Experiment Video

Updated: May 12, 2026

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
06:24

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

[Molecular targets of tea polyphenols and its roles of anticancer drugs in experimental therapy]

Shu-Zhen Chen1, Yong-Su Zhen

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. bjcsz@imb.pumc.edu.cn

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|April 23, 2013
PubMed

Insights

Green tea polyphenols (TPs) show anticancer effects by targeting multiple molecular pathways. TPs enhance chemotherapy efficacy, reverse drug resistance, and reduce treatment side effects.

Area of Science:

  • Phytochemistry and Pharmacology
  • Molecular Oncology
  • Cancer Therapeutics

Context:

  • Green tea polyphenols (TPs) are bioactive compounds with demonstrated anticancer properties.
  • Understanding the molecular mechanisms of TPs is crucial for optimizing cancer prevention and treatment strategies.
  • TPs interact with various cellular pathways implicated in cancer development and progression.

Purpose:

  • To elucidate the multifaceted molecular mechanisms by which tea polyphenols (TPs) exert anticancer effects.
  • To investigate the potential of TPs as adjuncts in cancer therapy, including their role in enhancing conventional treatments and overcoming drug resistance.
  • To explore the protective effects of TPs against chemotherapy-induced toxicity.

Summary:

  • Tea polyphenols (TPs) modulate key signaling pathways, including growth factor receptor pathways, MAPK, AP-1, NF-κB, and COX-2.
  • TPs inhibit enzymes like dihydrofolate reductase and telomerase, and affect DNA methylation and matrix metalloproteinases.
  • TPs enhance the efficacy of traditional and targeted anticancer drugs, reverse multidrug resistance, and mitigate chemotherapy-induced side effects like nephrotoxicity and DNA damage.

Impact:

  • TPs demonstrate significant potential as biochemical modulators to augment antitumor effects and improve cancer treatment outcomes.
  • The findings support the use of TPs to enhance the effectiveness of existing cancer therapies and reduce associated toxicities.
  • TPs offer a promising natural compound-based approach for cancer management, including overcoming drug resistance and enhancing immunomodulation for vaccine therapy.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...